Metastatic Ovarian Cancer

Oncology·MeSH: Ovarian Neoplasms

Prevalence

24.0 / 100K

Incidence

10.6 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Metastatic Ovarian Cancer?

There are 1 clinical trial targeting Metastatic Ovarian Cancer tracked by BioSniper.

What is the prevalence of Metastatic Ovarian Cancer?

The estimated prevalence of Metastatic Ovarian Cancer is approximately 24.0 per 100,000 population.

Deep-dive into Metastatic Ovarian Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Metastatic Ovarian Cancer — Drugs in Development & Clinical Trials | BioSniper